Evercore ISI lowered the firm’s price target on Inspire Medical (INSP) to $55 from $62 and keeps an Outperform rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSP:
- Inspire Medical price target lowered to $55 from $70 at Mizuho
- Inspire Medical price target lowered to $65 from $70 at Stifel
- Piper downgrades Inspire Medical to Neutral on guidance cut
- Inspire Medical price target lowered to $50 from $63 at Baird
- Inspire Medical downgraded at BofA on cloudy path back to growth